Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CaspoKin: Pharmacokinetics of Caspofungin in ICU Patients
NCT02596984Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Mar 2015
- Primary completion
- May 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of caspofungin in invasive candidiasis, sponsored by CHU Saint-Etienne. Primary endpoints: Caspofungin clearance at day 4 and Caspofungin volume of distribution at day 4. Started Mar 2015; status: completed.
02
Drugs
caspofungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT02596984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596984.